Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This observational study is following people with depression, psychosis, or bipolarity to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This study is looking at care and outcomes for people with bipolarity or bipolarity Type 1. Taking part may give some people access to Glucose, but direct benefit is not guaranteed.
This observational study is looking at how a digital support tool works for people with bipolarity in routine care. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
This study is looking at examine the efficacy, safety, and tolerability of CYB003 compared to matching placebo as adjunctive treatment in participants with depression for people with depression. Participants receive CYB003 or placebo and complete study visits and assessments.
This study is comparing Low Dose 5-hydroxytryptophan with placebo for people with depression. Participants receive Low Dose 5-hydroxytryptophan or placebo and complete study visits and assessments.
This study is looking at whether a digital support tool can help people with Hiv, Depression, or Anxiety. Participants take part in a digital support tool and complete follow-up assessments.
This study is looking at whether Deprexis can help people with Depression. Participants take part in the therapy or support program and complete follow-up questionnaires or assessments.
This study is looking at whether a digital support tool can help people with Executive Dysfunction, Depression, or Stroke. Participants take part in a digital support tool and complete follow-up assessments.
This study is looking at whether Ketamine-assisted psychotherapy can help people with Depression. Participants take part in Ketamine-assisted psychotherapy and complete follow-up assessments.
This observational study is following people with Postpartum Depression to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
This observational study is following people with Anxiety and Depression to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This study is looking at care and outcomes for people with Depression and CVD. Taking part may give some people access to psychoeducation, but direct benefit is not guaranteed.
This study is comparing Zelquistinel with placebo for people with depression. Participants receive Zelquistinel or placebo and complete study visits and assessments.
This study is looking at whether a digital support tool can help people with Depression, Pain, or Cognitive Impairment. Participants take part in a digital support tool and complete follow-up assessments.
This study is looking at whether a digital support tool can help people with Treatment Resistant Depression. Participants take part in a digital support tool and complete follow-up assessments.
This study is looking at whether a digital support tool can help people with Knee Osteoarthritis or Depression. Participants take part in a digital support tool and complete follow-up assessments.
This study is comparing Azetukalner, an experimental Kv7 potassium-channel opener, with placebo for people with depression. Participants receive Azetukalner or placebo and complete study visits and assessments.
This study is comparing Azetukalner, an experimental Kv7 potassium-channel opener, with placebo for people with depression. Participants receive Azetukalner or placebo and complete study visits and assessments.
This study is comparing Brenipatide with placebo for people with major depression. Participants receive Brenipatide or placebo and complete study visits and assessments.
This study is looking at care and outcomes for people with Depression. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
This study is testing whether CYB003, compared with placebo, is safe and helpful as an add-on treatment for people with depression. Participants receive CYB003 or placebo and complete study visits and assessments.
This observational study is following people with Postpartum Depression or Pregnancy to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
This study is looking at care and outcomes for people with depression. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
This study is comparing Icalcaprant with placebo for people with depression. Participants receive Icalcaprant or placebo and complete study visits and assessments.
This observational study is following people with Treatment Resistant Depression to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.